Quarterly report pursuant to Section 13 or 15(d)

Diluted Loss Per Share

v3.21.2
Diluted Loss Per Share
9 Months Ended
May 31, 2021
Earnings Per Share [Abstract]  
DILUTED LOSS PER SHARE
18. DILUTED LOSS PER SHARE

The Company’s potentially dilutive instruments are convertible debentures and stock options and share purchase warrants. Conversion of these instruments would have been anti-dilutive for the periods presented and consequently, no adjustment was made to basic loss per share to determine diluted loss per share. These instruments could potentially dilute earnings per share in future periods.


For the nine months ended May 31, 2021 and 2020, the following stock options, share purchase warrants and convertible securities were excluded from the computation of diluted loss per share as the result of the computation was anti-dilutive:


    Nine months
ended
May 31,
2021
    Nine months
ended
May 31,
2020
 
             
Share purchase options     7,250,000       9,808,333  
Share purchase warrants     38,157,987       50,660,474  
Convertible securities     161,952,638       39,593,517  
      207,360,625       100,062,324